History of Chugai Pharmaceutical

Understanding Chugai’s history that fostered the business philosophy “Innovation all for the patients”

2020
2020

Tatsuro Kosaka appointed as Representative Director, Chairman and Osamu Okuda appointed as Representative Director, President (Mar.)

Announced CHUGAI DIGITAL VISION 2030 to Accelerate Digital Transformation (Mar.)

Approval of Enspryng®, a neuromyelitis optica spectrum disorder (NMOSD) treatment, in the United States (Aug.)

Launched Enspryng®, a neuromyelitis optica spectrum disorder (NMOSD) treatment (Aug.)

Learn more about the turning points of this age

  1. Promotion of Personalized Healthcare (2000s -)
  • Like
  • Tweet
  • LINE it!
  • E-mail

History of Chugai Pharmaceutical

Back to top